Stay updated on Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor update to the site's revision label with no visible impact on content or behavior.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content changes are evident.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a technical site update with no visible impact on the study page content or navigation.SummaryDifference0.0%

- Check27 days agoChange DetectedThe location Brno-Židenice, Czechia, 615 00 was added and Brno - Zidenice, Czechia, 615 00 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded a new publication citation under Publications: BMJ Open. 2025 Dec 24;15(12):e082366, 'Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.' To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.